Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2025-02-12 Sale | 2025-02-14 4:00 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.59 | $46,360 | 2,871,260 (Indirect) | View |
2025-02-10 Sale | 2025-02-12 8:45 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 3,878 | $11.72 | $45,435 | 2,875,260 (Indirect) | View |
2025-02-06 Sale | 2025-02-11 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.51 | $50,020 | 2,879,158 (Indirect) | View |
2025-02-04 Sale | 2025-02-06 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.01 | $48,029 | 2,883,138 (Indirect) | View |
2025-01-31 Sale | 2025-02-04 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.49 | $45,960 | 2,887,138 (Indirect) | View |
2025-01-29 Sale | 2025-01-31 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.4 | $45,600 | 2,891,138 (Indirect) | View |
2025-01-27 Sale | 2025-01-29 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.35 | $45,380 | 2,895,138 (Indirect) | View |
2025-01-23 Sale | 2025-01-27 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.69 | $42,760 | 2,899,138 (Indirect) | View |
2025-01-21 Sale | 2025-01-24 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.74 | $42,960 | 2,903,138 (Indirect) | View |
2025-01-16 Sale | 2025-01-21 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.71 | $42,860 | 2,907,138 (Indirect) | View |
2025-01-14 Sale | 2025-01-16 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.62 | $42,480 | 2,911,138 (Indirect) | View |
2025-01-10 Sale | 2025-01-14 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 1,113 | $10.02 | $11,157 | 2,915,138 (Indirect) | View |
2025-01-03 Sale(A) | 2025-01-10 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 833 | $11.85 | $9,871 | 2,918,467 (Indirect) | View |
2025-01-06 Sale | 2025-01-08 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 2,216 | $10.08 | $22,336 | 2,916,251 (Indirect) | View |
2024-01-03 Sale | 2025-01-06 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.89 | $47,543 | 2,918,467 (Indirect) | View |
2024-12-30 Sale | 2025-01-02 4:06 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.4 | $49,600 | 2,922,467 (Indirect) | View |
2024-12-26 Sale | 2024-12-30 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.64 | $50,553 | 2,926,467 (Indirect) | View |
2024-12-23 Sale | 2024-12-26 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $12.1 | $48,399 | 2,930,467 (Indirect) | View |
2024-12-19 Sale | 2024-12-23 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $10.86 | $43,440 | 2,934,467 (Indirect) | View |
2024-12-17 Sale | 2024-12-19 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 4,000 | $11.21 | $44,852 | 2,938,467 (Indirect) | View |
2024-06-28 Sale | 2024-07-01 6:00 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $12 | $41,438 | 280,476 (Indirect Direct) | View |
2024-05-01 Sale | 2024-05-02 6:19 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $14.13 | $282,577 | 283,928 (Indirect Direct) | View |
2024-04-01 Sale | 2024-04-03 4:01 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $16.15 | $323,000 | 303,928 (Indirect Direct) | View |
2024-03-15 Sale | 2024-03-19 4:47 pm | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $17.26 | $345,200 | 323,928 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2025-01-05 Option Award | 2025-01-07 4:05 pm | N/A 2035-01-05 | GYRE THERAPEUTICS INC. | GYRE | Zhang Ping Director | 52,000 | $0 | 52,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 9:13 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director | 52,000 | $0 | 52,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 9:10 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Parry Renate Director | 52,000 | $0 | 52,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 9:07 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director | 52,000 | $0 | 52,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 9:05 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Carmichael Gordon Director | 52,000 | $0 | 52,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 9:01 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Ma Songjiang President | 26,000 | $0 | 26,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 8:58 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Eastling Thomas Wilson Director | 26,000 | $0 | 26,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 8:56 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 26,000 | $0 | 26,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 8:53 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Chen Ruoyu Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
2024-08-14 Option Award | 2024-08-16 8:50 pm | N/A 2034-08-14 | GYRE THERAPEUTICS INC. | GYRE | Ying Han Chief Executive Officer | 341,000 | $0 | 341,000 (Direct) | View |
2024-08-06 Option Award | 2024-08-08 4:31 pm | N/A 2034-08-06 | GYRE THERAPEUTICS INC. | GYRE | Epstein David M. Director | 1,866 | $0 | 1,866 (Direct) | View |
2024-06-28 Exercise | 2024-07-01 6:00 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $0 | 280,476 (Direct) | View |
2024-06-28 Exercise | 2024-07-01 6:00 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 3,452 | $6.93 | 280,476 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 6:19 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 283,928 (Direct) | View |
2024-05-01 Exercise | 2024-05-02 6:19 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 283,928 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 4:01 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 303,928 (Direct) | View |
2024-04-01 Exercise | 2024-04-03 4:01 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 303,928 (Direct) | View |
2024-03-20 Option Award | 2024-03-21 8:31 pm | N/A 2034-03-20 | GYRE THERAPEUTICS INC. | GYRE | Nussbaum Rodney L Director | 1,866 | $0 | 1,866 (Direct) | View |
2024-03-15 Exercise | 2024-03-19 4:47 pm | N/A 2033-10-31 | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $0 | 323,928 (Direct) | View |
2024-03-15 Exercise | 2024-03-19 4:47 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | USMAN NASSIM Director | 20,000 | $6.93 | 323,928 (Direct) | View |
2023-11-20 Option Award | 2023-11-22 7:55 pm | N/A 2030-10-31 | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 5,613,652 | $0 | 11,294,404 (Direct) | View |
2023-10-30 Other | 2023-11-22 7:55 pm | N/A N/A | GYRE THERAPEUTICS INC. | GYRE | Luo Ying Director | 2,840,376 | $0 | 11,294,404 (Indirect) | View |